세계의 대용량 비경구 의약품(LVP) 시장 규모 : 용량별, 용도별, 최종사용자별, 지역 범위별 및 예측

Large Volume Parenteral (LVP) Market Size And Forecast

Large Volume Parenteral (LVP) Market size was valued at USD 13.02 Billion in 2024 and is projected to reach USD 25.72 Billion by 2032, growing at a CAGR of 8.88% from 2026 to 2032.

The rising demand for safer, faster, and more effective methods for drug administration in patients leads to drive the market growth of the Global Large Volume Parenteral (LVP) Market. Also, patients now preferring to take administration for a single dose of vaccines or drugs to treat chronic diseases propels the market growth. The Global Large Volume Parenteral (LVP) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Large Volume Parenteral (LVP) Market Definition

Parenterals are injectable preparations, sterile products which are intended for administration by way of injection, infusion, or implantation into the body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml which is terminally sterilized by heat. These parenteral are included with intravenous solutions which are sold to be in bags or bottles containing 100ml or of greater sizes. If a large quantity is required then it is packaged in large volumes. When preparation of parental takes place parentals are sterile, solid dosage form or pyrogen-free liquids, which contain one or more active ingredients boxed in single or multi-dose containers.

Parenterals are meant to be administered by way of infusion, transplantation, or injection in the body. These are free of physical, chemical, and biological contamination. As the biotechnology field is developing there is a development in a certain number of drugs administered parenterally because the parenteral route is the best, when the oral route is not suitable. Maximum efficacy and bio-availability are provided by Parenterals and are preferred over oral dosages in a vast number of instances.

Global Large Volume Parenteral (LVP) Market Overview

The increase in health-related issues leads to the increasing hospitalization rate of people and due to this, there is a rise in demand for faster, safer, and effective administration of drugs which drives the growth of the Global Large Volume Parenteral (LVP) Market. Surgeries are increasing at a higher pace and because of this, there is an increase in the need for a faster route of drug administration and a growing preference for single-dose administration of vaccines and drugs.

Also, as the demand is increasing there is an increase in the local manufacturing which is expected to drive the market. The parental route helps in administering by providing an accurate dose of medication because the majority of the drug is directly absorbed in circulation, bypassing the gastrointestinal tract Parental route helps in administering and also drives the market growth. Patients with chronic and other lifestyle-related diseases are increasing and because of it, they were hospitalized.

The introduction of single-dosage nervous system disorders, oncology, and diabetes creates lucrative opportunities for the Global Large Volume Parenteral (LVP) Market. Also, patients are now preferring single-dose administration of vaccines and drugs to treat chronic diseases which drives the growth of the Global Large Volume Parenteral (LVP) Market. Increased demand in combination with manufacturing delays hampers the growth of the market. Also, LVPs quality issues and other manufacturing problems will result in a shortage of parenteral will restrain the market.

The Global Large Volume Parenteral (LVP) Market is segmented on the basis of Volume, Application, End-User, And Geography.

Large Volume Parenteral (LVP) Market, By Volume

100 ml - 250 ml

250 ml - 500 ml

500 ml - 1000 ml

1000 ml - 2000 ml

2000 ml and more

Based on Volume, The market is bifurcated into 100 ml - 250 ml, 250 ml - 500 ml, 500 ml - 1000 ml, 1000 ml - 2000 ml, and 2000 ml and more. In 2022, the 250 ml - 500 ml large volume parenteral (LVP) segment dominated the market. Large Volume Parenteral (LVP), often known as LVPs, are sterile preparations of 250 mL or higher that are delivered parenterally. For example, the most popular LVPs are IV solutions made from a standard/base solution, like 0.9% sodium chloride, dextrose 5% in normal saline (D5NS), dextrose 5% in water (D5W), and Lactate Ringer (L.R.) solution. LVPs are intravenous solutions offered in bags or bottles holding 100 mL or more (250 mL, 500 mL, 1 L).

Large Volume Parenteral (LVP) Market, By Application

• Therapeutic Injections
• Fluid Balance Injections
• Nutritious Injections

Based on Application, The market is bifurcated into Therapeutic Injections, Fluid Balance Injections, and Nutritious Injections. The nutritious injections by application segment are expected to dominate the Global Large Volume Parenteral (LVP) Market during the forecast period, owing to growing applications in the geriatric and pediatric populations, as well as its requirement in the management of chronic diseases such as ulcerative colitis and cancer. These patients require a continuous feeding system to compensate for nutritional inadequacies, paving the way for the segment.

Large Volume Parenteral (LVP) Market, By End-User

• Hospitals
• Medical Centers
• Others

Based on End-User, The market is bifurcated into Hospitals, Medical Centres, and Others. Hospitals and healthcare facilities will dominate the overall market for the Global Large Volume Parenteral (LVP) Market.

Large Volume Parenteral (LVP) Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• On the basis of Regional Analysis, The Global Large Volume Parenteral (LVP) Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America led the global market throughout the projection period due to its significant investment in healthcare research by public and private organizations, its technologically cutting-edge medical equipment, and its regulatory agencies and industry's close partnerships with universities.
• Additionally, favorable payment rules have increased hospital admissions, which is expected to enhance utilization rates in this area. For IV nutrition, the reimbursement picture is encouraging. Medicare provides patients with coverage for up to 80% of the costs associated with parenteral and enteral nourishment in the US, including the cost of medical supplies, doctor visits, and other related healthcare services.

Key Players

The "Global Large Volume Parenteral (LVP) Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are B. Braun Melsungen AG, Fresenius Kabi AG, BML Parenteral Drugs, Pfizer, Inc, Otsuka Pharmaceutical, Kelun Pharma, Cook Pharma, Patheon, BAG Healthcare, Southwest Pharmaceuticals, Beximco Pharma, Baxter Healthcare Corporation.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
• Ace Matrix Analysis of Large Volume Parenteral (LVP) Market
• Market Attractiveness
• The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Large Volume Parenteral (LVP) Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
• Geographical Representation of Large Volume Parenteral (LVP) Market
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. The porter's five forces model can be used to assess the competitive landscape in the Global Large Volume Parenteral (LVP) Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET

• 1.1 Market Definition
• 1.2 Market Segmentation
• 1.3 Research Timelines
• 1.4 Assumptions
• 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data Mining
• 2.2 Data Triangulation
• 2.3 Bottom-Up Approach
• 2.4 Top-Down Approach
• 2.5 Research Flow
• 2.6 Key Insights from Industry Experts
• 2.7 Data Sources

3 EXECUTIVE SUMMARY

• 3.1 Market Overview
• 3.2 Ecology Mapping
• 3.3 Absolute Market Opportunity
• 3.4 Market Attractiveness
• 3.5 Global Large Volume Parenteral (LVP) Market Geographical Analysis (CAGR %)
• 3.6 Global Large Volume Parenteral (LVP) Market, By Volume (USD Million)
• 3.7 Global Large Volume Parenteral (LVP) Market, By Application (USD Million)
• 3.8 Global Large Volume Parenteral (LVP) Market, By End User (USD Million)
• 3.9 Future Market Opportunities
• 3.10 Global Market Split
• 3.11 Product Life Line

4 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET OUTLOOK

• 4.1 Global Large Volume Parenteral (LVP) Evolution
• 4.2 Drivers
  • 4.2.1 Driver1
  • 4.2.2 Driver 2
• 4.3 Restraints
  • 4.3.1 Restraint1
  • 4.3.2 Restraint 2
• 4.4 Opportunities
  • 4.4.1 Opportunity1
  • 4.4.2 Opportunity 2
• 4.5 Porters Five Force Model
• 4.6 Value Chain Analysis
• 4.7 Pricing Analysis
• 4.8 Macroeconomic Analysis

5 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET, BY VOLUME

• 5.1 Overview
• 5.2100 ml - 250 ml
• 5.3 250 ml - 500 ml
• 5.4 500 ml -1000 ml
• 5.51000 ml - 2000 ml
• 5.6 2000 ml and more

6 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Therapeutic Injections
• 6.3 Fluid Balance Injections
• 6.4 Nutritious Injections

7 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Medical Centers
• 7.4 Others

8 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL LARGE VOLUME PARENTERAL (LVP) MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Developments
• 9.4 Company Regional Footprint
• 9.5 Company Industry Footprint
• 9.6 ACE Matrix

10 COMPANY PROFILES

• 10.1 B. Braun Melsungen AG
  • 10.1.1 Company Overview
  • 10.1.2 Company Insights
  • 10.1.3 Business Breakdown
  • 10.1.4 Product Benchmarking
  • 10.1.5 Key Developments
  • 10.1.6 Winning Imperatives
  • 10.1.7 Current Focus & Strategies
  • 10.1.8 Threat from Competition
  • 10.1.9 SWOT Analysis
• 10.2 Fresenius Kabi AG
  • 10.2.1 Company Overview
  • 10.2.2 Company Insights
  • 10.2.3 Business Breakdown
  • 10.2.4 Product Benchmarking
  • 10.2.5 Key Developments
  • 10.2.6 Winning Imperatives
  • 10.2.7 Current Focus & Strategies
  • 10.2.8 Threat from Competition
  • 10.2.9 SWOT Analysis
• 10.3 BML Parenteral Drugs
  • 10.3.1 Company Overview
  • 10.3.2 Company Insights
  • 10.3.3 Business Breakdown
  • 10.3.4 Product Benchmarking
  • 10.3.5 Key Developments
  • 10.3.6 Winning Imperatives
  • 10.3.7 Current Focus & Strategies
  • 10.3.8 Threat from Competition
  • 10.3.9 SWOT Analysis
• 10.4 Pfizer, Inc
  • 10.4.1 Company Overview
  • 10.4.2 Company Insights
  • 10.4.3 Business Breakdown
  • 10.4.4 Product Benchmarking
  • 10.4.5 Key Developments
  • 10.4.6 Winning Imperatives
  • 10.4.7 Current Focus & Strategies
  • 10.4.8 Threat from Competition
  • 10.4.9 SWOT Analysis
• 10.5 Otsuka Pharmaceutical
  • 10.5.1 Company Overview
  • 10.5.2 Company Insights
  • 10.5.3 Business Breakdown
  • 10.5.4 Product Benchmarking
  • 10.5.5 Key Developments
  • 10.5.6 Winning Imperatives
  • 10.5.7 Current Focus & Strategies
  • 10.5.8 Threat from Competition
  • 10.5.9 SWOT Analysis
• 10.6 Kelun Pharma
  • 10.6.1 Company Overview
  • 10.6.2 Company Insights
  • 10.6.3 Business Breakdown
  • 10.6.4 Product Benchmarking
  • 10.6.5 Key Developments
  • 10.6.6 Winning Imperatives
  • 10.6.7 Current Focus & Strategies
  • 10.6.8 Threat from Competition
  • 10.6.9 SWOT Analysis
• 10.7 Cook Pharma
  • 10.7.1 Company Overview
  • 10.7.2 Company Insights
  • 10.7.3 Business Breakdown
  • 10.7.4 Product Benchmarking
  • 10.7.5 Key Developments
  • 10.7.6 Winning Imperatives
  • 10.7.7 Current Focus & Strategies
  • 10.7.8 Threat from Competition
  • 10.7.9 SWOT Analysis
• 10.8 Patheon
  • 10.8.1 Company Overview
  • 10.8.2 Company Insights
  • 10.8.3 Business Breakdown
  • 10.8.4 Product Benchmarking
  • 10.8.5 Key Developments
  • 10.8.6 Winning Imperatives
  • 10.8.7 Current Focus & Strategies
  • 10.8.8 Threat from Competition
  • 10.8.9 SWOT Analysis
• 10.9 BAG Healthcare
  • 10.9.1 Company Overview
  • 10.9.2 Company Insights
  • 10.9.3 Business Breakdown
  • 10.9.4 Product Benchmarking
  • 10.9.5 Key Developments
  • 10.9.6 Winning Imperatives
  • 10.9.7 Current Focus & Strategies
  • 10.9.8 Threat from Competition
  • 10.9.9 SWOT Analysis
• 10.10 Southwest Pharmaceuticals
  • 10.10.1 Company Overview
  • 10.10.2 Company Insights
  • 10.10.3 Business Breakdown
  • 10.10.4 Product Benchmarking
  • 10.10.5 Key Developments
  • 10.10.6 Winning Imperatives
  • 10.10.7 Current Focus & Strategies
  • 10.10.8 Threat from Competition
  • 10.10.9 SWOT Analysis
• 10.11 Baxter Healthcare Corporation.
  • 10.11.1 Company Overview
  • 10.11.2 Company Insights
  • 10.11.3 Business Breakdown
  • 10.11.4 Product Benchmarking
  • 10.11.5 Key Developments
  • 10.11.6 Winning Imperatives
  • 10.11.7 Current Focus & Strategies
  • 10.11.8 Threat from Competition
  • 10.11.9 SWOT Analysis

11 VERIFIED MARKET INTELLIGENCE

• 11.1 About Verified Market Intelligence
• 11.2 Dynamic Data Visualization